Drugs / memory T cells
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT04578210 | Sep 2020 → Jan 2022 | COVID-19 | Instituto de Investigación Hospital Universitario La Paz | Completed | Met primary |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | memory T cells | “Treatment of arm A consists of the administration of escalating doses of memory T cells, plus standard of care (SoC).” PMID 34600562 ↗ Oct 2021 |
| Modality | Cell therapy | “adoptive cell therapy with NK cells or memory T cells” NCT04578210 ↗ |